Development and Scale Up Considerations for Nanosuspension Dosage Forms

Sep 13, 2021 12:00:00 AM

How to Successfully Utilize ASDs for Drug Delivery of Insoluble Drugs

Aug 20, 2021 12:00:00 AM

Top Considerations When Developing Formulations for Injectable Solutions

Aug 11, 2021 12:00:00 AM

Considerations in Development and Manufacturing of Complex Injectables for Early Phase Studies

Aug 3, 2021 12:00:00 AM

Ascendia Chief Business Officer Robert Bloder to Sit on CDMO Panel at CPhI North America

Jul 26, 2021 12:00:00 AM

Ascendia to Highlight How to Make Insoluble Soluble During CPhI North America

Jul 20, 2021 12:00:00 AM

Formulation Forum: Nanosuspension Dosage Forms

Jul 6, 2021 12:00:00 AM

Ascendia to Conduct Virtual Meetings During DCAT Week

Jul 1, 2021 12:00:00 AM

Meet Ascendia at BIO 2021 – Industry’s Top Networking Virtual Show

Jun 8, 2021 12:00:00 AM

Leading Pharma, Biopharma Industry Report Features Ascendia

May 24, 2021 12:00:00 AM

Factors to Consider When Selecting a CDMO for Complex Injectables Development and Manufacture

May 3, 2021 12:00:00 AM

Ascendia Pharmaceuticals Secures Growth Equity Investment from Signet Healthcare Partners

Apr 8, 2021 12:00:00 AM